297.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Cencora Inc Borsa (COR) Ultime notizie
Cencora Surges to 261st in Daily Rankings with 3.90 Billion Trading Volume - AInvest
Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - BioSpace
Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st
Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia
Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha
Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Nigeria
Lobbying Update: $20,000 of CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) lobbying was just disclosed - Quiver Quantitative
Here's What to Expect From Cencora's Next Earnings Report - MSN
Cencora, Inc. (COR): If It Was Down, I’d Say “Double Down And Buy,” Says Jim Cramer - Insider Monkey
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Here's Why You Should Add Cencora Stock to Your Portfolio Now - Yahoo Finance
Cencora to Announce Q3 2025 Results on August 6 with Live Webcast and Conference Call - MSN
Fund Update: FERGUSON WELLMAN CAPITAL MANAGEMENT, INC added 79,430 shares of CENCORA ($COR) to their portfolio - Quiver Quantitative
Here's What To Expect From Cencora's Next Earnings Report - Barchart.com
Cencora Enhances Receivables Purchase Agreement for Liquidity - TipRanks
Cencora Trading Volume Drops 40.8% to $385 Million Ranking 278th in Market - AInvest
Mizuho maintains Cencora stock rating on strong Walgreens data - Investing.com
Cencora's Trading Volume Drops 44.5% to 2.74 Billion, Ranks 340th Despite Two-Day Gain - AInvest
Cencora's Insider Exodus: Risk or Opportunity? - AInvest
Insider Sell: Silvana Battaglia Sells Shares of Cencora Inc (COR) - GuruFocus
Three fund managers share picks for tariff-resistant U.S. stocks - The Globe and Mail
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga
Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MSN
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health boosts profit view banking on specialty drugs unit growth - Reuters
Is Cencora Stock Outperforming The Dow? - Barchart.com
Is Cencora Stock Outperforming the Dow? - The Globe and Mail
Cencora, Inc. (COR) Enhances Financial Flexibility with Amended Credit Agreements - GuruFocus
Cencora Enhances Financial Flexibility with Credit Amendments - TipRanks
Cencora IncIncreases Revolving Credit Facility To $4.5 Billion - MarketScreener
Cardinal Health, Cencora upgraded at Wells Fargo on industry outlook - MSN
Cravath Advises on €1B Cencora Notes Offering - Lawyer Monthly
Mizuho Adjusts Price Target on Cencora to $316 From $315, Maintains Outperform Rating - marketscreener.com
Cencora (NYSE:COR) Upgraded by Wells Fargo & Company to “Overweight” Rating - Defense World
Wells Fargo Upgrades Cencora (COR) Stock to Overweight, Lifts PT - MSN
Cencora (COR) Receives Upgrade as Analysts Set New Price Target - GuruFocus
Wells Fargo Upgrades Cencora (COR) - Nasdaq
Wells Fargo upgrades Cencora stock rating, raises price target to $337 - Investing.com Nigeria
Wells Fargo Upgrades Cencora (COR) with Raised Price Target | COR Stock News - GuruFocus
Assessing Cencora: Insights From 6 Financial Analysts - Benzinga
Cencora (COR) Receives Upgrade as Analysts Set New Price Target | COR Stock News - GuruFocus
Wells Fargo Elevates Cencora (COR) to Overweight with Raised Price Target | COR Stock News - GuruFocus
Top Cencora Executive Cashes In on Significant Stock Sale! - TipRanks
Insider Sell Alert: Lazarus Krikorian Sells 3,000 Shares of Cenc - GuruFocus
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What is Zacks Research’s Estimate for Cencora Q2 Earnings? - Defense World
Cencora, Inc. Declares Quarterly Cash Dividend, Payable on June 2, 2025 - marketscreener.com
What is Zacks Research’s Estimate for Cencora Q3 Earnings? - Defense World
Nephron Research Adjusts Cencora Price Target to $335 From $325 - marketscreener.com
Cencora, Inc. (COR) Announces Board Changes: New Appointment and Resignation - GuruFocus
Cencora appoints new board member to boost growth By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):